On August 11, Zhonghong Medical(300981) issued an announcement that its holding subsidiary Jiangxi Kelun Medical EquipmentKelun Medical Devices recently participated in bidding for the seventh and eighth rounds of Jiangsu Province's medical consumables procurement program, as well as Shaanxi Province's centralized volume-based procurement program for indwelling catheters and foam dressings. Based on the winning results, some of Kelun Medical Devices' products, including disposable vacuum blood collection tubes and indwelling catheters, are expected to be selected for these centralized volume-based procurement programs. The winning prices and quantities have not been disclosed.

The sales revenue of Kelun Medical Equipment's disposable vacuum blood collection tubes and indwelling needles in 2024 were RMB 6.53 million and RMB 3.94 million, respectively, accounting for 3.55% and 2.14% of its operating income in 2024, and also accounting for 0.27% and 0.16% of the company's operating income in 2024, respectively.

During the procurement cycle of the proposed selected products, medical institutions in the purchasing areas will give priority to the use of the company's proposed selected products. It is expected that this will be conducive to expanding market sales, increasing market share, and thereby enhancing brand influence, which will have a positive impact on the company's long-term development.

In the first quarter of 2025, Zhonghong Medical achieved revenue of 629 million yuan and net profit attributable to shareholders of the parent company of 18.92 million yuan.

https://finance.eastmoney.com/a/202508113481590229.html